<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Approach to evaluating pregnant patients with elevated liver biochemical and function tests
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Approach to evaluating pregnant patients with elevated liver biochemical and function tests
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Approach to evaluating pregnant patients with elevated liver biochemical and function tests
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Richard H Lee, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Nancy Reau, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Keith D Lindor, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Charles J Lockwood, MD, MHCM
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kristen M Robson, MD, MBA, FACG
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Vanessa A Barss, MD, FACOG
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jul 24, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Elevated liver biochemical and function tests in pregnant patients may pose a challenge for the consulting clinician. Liver abnormalities detected during pregnancy require diagnostic evaluation similar to the evaluation of the nonpregnant patient but is also informed by gestational age and expected physiologic changes of pregnancy.
        </p>
        <p>
         Liver disease during pregnancy can be categorized by the following characteristics:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diseases that are unique to pregnancy: Some are primary liver diseases (eg, intrahepatic cholestasis of pregnancy, acute fatty liver of pregnancy), and others are systemic diseases with hepatic manifestations (eg, preeclampsia with severe features [including eclampsia; hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome]; hyperemesis):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3560.html" rel="external">
          "Intrahepatic cholestasis of pregnancy"
         </a>
         .)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3619.html" rel="external">
          "Acute fatty liver of pregnancy"
         </a>
         .)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6778.html" rel="external">
          "HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets)"
         </a>
         .)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6814.html" rel="external">
          "Preeclampsia: Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6792.html" rel="external">
          "Nausea and vomiting of pregnancy: Clinical findings and evaluation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diseases that are exacerbated by pregnancy: Pregnancy-related physiologic changes may increase the risk of liver-related diseases that may also occur in nonpregnant patients. Examples of such diseases include gallstones and vascular diseases (eg, Budd-Chiari syndrome). (See
         <a class="medical medical_review" href="/z/d/html/15095.html" rel="external">
          "Gallstone diseases in pregnancy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3562.html" rel="external">
          "Budd-Chiari syndrome: Epidemiology, clinical manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diseases that are not related but are coincidental to pregnancy (eg, acute viral hepatitis). (See
         <a class="medical medical_review" href="/z/d/html/3564.html" rel="external">
          "Overview of coincident acute hepatobiliary disease in pregnant women"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         This topic will provide an overview of the evaluation of patients who do not have pre-existing liver disease but develop elevated liver biochemical and/or function tests during pregnancy. Our approach is largely consistent with society guidelines on liver disease during pregnancy [
         <a href="#rid1">
          1,2
         </a>
         ].
        </p>
        <p>
         Issues related to pregnant patients with pre-existing liver disease are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/3561.html" rel="external">
          "Pregnancy in women with pre-existing chronic liver disease"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          GENERAL PRINCIPLES
         </span>
        </p>
        <p class="headingAnchor" id="H1203520301">
         <span class="h2">
          Liver adaptation to normal pregnancy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Normal changes associated with pregnancy impact the patient's liver when assessed with physical examination, laboratory studies, and imaging [
         <a href="#rid3">
          3
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/407.html" rel="external">
          "Maternal adaptations to pregnancy: Gastrointestinal tract"
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Physical examination findings:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Skin: Spider angiomas and palmar erythema, which are classically associated with chronic liver disease, are common during pregnancy and usually disappear after delivery. It is presumed that the high estrogen level induced by pregnancy is responsible for these changes, as in nonpregnant patients with cirrhosis. The precise mechanism is unknown as the effects of estrogen on the cutaneous microvasculature are unclear [
         <a href="#rid4">
          4,5
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/456.html" rel="external">
          "Maternal adaptations to pregnancy: Skin and related structures", section on 'Vascular changes'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1253.html" rel="external">
          "Cirrhosis in adults: Etiologies, clinical manifestations, and diagnosis", section on 'Skin findings'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Abdomen: The liver may be displaced upward as the gravid uterus enlarges, and the liver is not typically palpable [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Blood biochemistries: Some blood biochemistries change as a result of normal pregnancy  (
         <a class="graphic graphic_table graphicRef114668" href="/z/d/graphic/114668.html" rel="external">
          table 1
         </a>
         ). For example, lower serum albumin (due to hemodilution) and elevated serum alkaline phosphatase (typically &lt;2 times the upper limit of normal and due to placental synthesis) are normal findings during pregnancy and do not require further evaluation [
         <a href="#rid6">
          6
         </a>
         ]. However, the following laboratory values should remain within the normal range during pregnancy, and thus, elevated levels prompt further evaluation:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Serum aminotransferases: Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are biochemical markers of liver injury. Elevations of aminotransferases often reflect hepatocellular damage or biliary obstruction.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Bilirubin: Bilirubin measures the liver's ability to detoxify metabolites and transport organic anions into bile.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Prothrombin time/international normalized ratio (INR): Prolonged prothrombin time may be seen in the setting of impaired liver synthetic function.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Liver biochemical and function tests are discussed in more detail separately. (See
         <a class="medical medical_review" href="/z/d/html/3576.html" rel="external">
          "Approach to the patient with abnormal liver biochemical and function tests", section on 'Common liver biochemical and function tests'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ultrasound examination: During normal pregnancy, the appearance of the liver and biliary tract on transabdominal ultrasound is typically normal.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3883109243">
         <span class="h2">
          Indications for baseline liver tests
         </span>
         <span class="headingEndMark">
          —
         </span>
         We obtain baseline liver biochemical and function tests in pregnant patients with any of the following (see
         <a class="medical medical_review" href="/z/d/html/446.html" rel="external">
          "Prenatal care: Initial assessment"
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         History of pregnancy-related liver disease in prior pregnancy (eg, intrahepatic cholestasis of pregnancy, preeclampsia; hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome; acute fatty liver)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         History of chronic hypertension or gestational hypertension
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Risk factors for liver disease (eg, metabolic syndrome, alcohol use disorder)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Viral hepatitis identified on prenatal screening (eg, hepatitis B surface antigen-positive or anti-hepatitis C virus antibody positive)
        </p>
        <p>
        </p>
        <p>
         Liver tests that are commonly measured include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Serum aminotransferases: ALT and aspartate aminotransferase AST
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Alkaline phosphatase
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Total bilirubin
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Prothrombin time/international normalized ratio
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Serum albumin
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H706197294">
         <span class="h1">
          PREVALENCE OF LIVER DISEASE IN PREGNANCY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Approximately 3 percent of all pregnancies are complicated by liver biochemical test abnormalities [
         <a href="#rid7">
          7,8
         </a>
         ]. Hospital discharge data from the Nationwide Inpatient Sample (a United States inpatient database) were used to evaluate the prevalence of liver disease in pregnant patients hospitalized for any reason. This database included over 40 million pregnancy hospitalizations from 2002 to 2010 and found the following liver disease diagnoses (the denominator for the frequency of each liver disease diagnosis is 1000 pregnancy hospitalizations) [
         <a href="#rid7">
          7
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diseases bundled together as liver disorders of pregnancy (eg, acute fatty liver of pregnancy, intrahepatic cholestasis of pregnancy, and postpartum hepatorenal syndrome): 7.18
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Gallbladder disease/cholelithiasis: 4.65
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hepatitis C virus infection: 1.70
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Biliary tract disease (biliary obstruction, cholangitis): 1.67
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hepatitis B virus infection: 0.96
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome: 0.95
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Alcohol-related liver disease: 0.30
        </p>
        <p>
        </p>
        <p>
         Prevalence data for liver disease in pregnant patients who do not require hospitalization are lacking.
        </p>
        <p class="headingAnchor" id="H1990049723">
         <span class="h1">
          EVALUATION OF ACUTE LIVER FAILURE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pregnant patients with acute severe liver injury (ie, serum aminotransferases typically more than 10 times the upper limit of normal, hepatic encephalopathy, and coagulopathy) have acute liver failure. Such patients require urgent consultation with maternal-fetal medicine and hepatology specialists and referral to a liver transplantation center.
        </p>
        <p>
         Causes of acute liver failure during pregnancy may be classified as:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pregnancy-related: Acute liver failure due to pregnancy-related causes generally occurs at ≥20 weeks of gestation. These obstetric emergencies include acute fatty liver of pregnancy or preeclampsia with severe features/eclampsia/hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome. (See
         <a class="medical medical_review" href="/z/d/html/3619.html" rel="external">
          "Acute fatty liver of pregnancy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6825.html" rel="external">
          "Preeclampsia: Antepartum management and timing of delivery"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nonpregnancy-related: Acute liver failure in pregnant patients may be due to nonpregnancy-related causes during any stage of pregnancy. Common causes of acute liver failure include acute viral hepatitis, drug-induced liver injury (eg,
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         ), and ischemic hepatitis. The evaluation and management of acute liver failure due to nonpregnancy-related causes are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/3574.html" rel="external">
          "Acute liver failure in adults: Etiology, clinical manifestations, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3570.html" rel="external">
          "Acute liver failure in adults: Management and prognosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h1">
          PATIENTS WITHOUT ACUTE LIVER FAILURE
         </span>
        </p>
        <p class="headingAnchor" id="H334119508">
         <span class="h2">
          Initial evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         The initial evaluation for a pregnant patient with elevated liver biochemistries but without acute liver failure is similar to the evaluation of a nonpregnant patient and includes history, physical examination, laboratory studies, and a liver ultrasound. (See
         <a class="medical medical_review" href="/z/d/html/3576.html" rel="external">
          "Approach to the patient with abnormal liver biochemical and function tests"
         </a>
         .)
        </p>
        <p>
         For pregnant patients, assessing clinical features and interpreting the liver biochemistries must also take into account the timing of symptom onset and gestational age because these factors inform the differential diagnosis for diseases that are unique to pregnancy.
        </p>
        <p class="headingAnchor" id="H3157096095">
         <span class="h3">
          Patient history and presentation
         </span>
         <span class="headingEndMark">
          —
         </span>
         The patient's clinical presentation and history may suggest a possible cause(s) for elevated liver biochemistries:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Timing of symptom onset: The timing of symptom onset (gestational age) can help guide the evaluation  (
         <a class="graphic graphic_table graphicRef57913" href="/z/d/graphic/57913.html" rel="external">
          table 2
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Gestational age &lt;20 weeks: Severe nausea and emesis with onset in the first trimester suggests hyperemesis gravidarum. (See
         <a class="medical medical_review" href="/z/d/html/6792.html" rel="external">
          "Nausea and vomiting of pregnancy: Clinical findings and evaluation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Gestational age ≥20 weeks: New onset hypertension at ≥20 weeks gestation is concerning for Hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome or preeclampsia with severe features. Diagnostic criteria for hypertensive disorders during pregnancy are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/126975.html" rel="external">
          "Hypertensive disorders in pregnancy: Approach to differential diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Symptoms of nausea, vomiting, headache, and abdominal pain in the third trimester are concerning for acute fatty liver of pregnancy. (See
         <a class="medical medical_review" href="/z/d/html/3619.html" rel="external">
          "Acute fatty liver of pregnancy"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Risk factors for exposure to potential hepatotoxins (medications, dietary and herbal supplements, alcohol use, illicit substance use) (see
         <a class="medical medical_review" href="/z/d/html/3571.html" rel="external">
          "Drug-induced liver injury"
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Risk factors for nonalcohol-associated fatty liver disease (metabolic syndrome, dyslipidemia) (see
         <a class="medical medical_review" href="/z/d/html/5372.html" rel="external">
          "Obesity in adults: Prevalence, screening, and evaluation"
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Symptoms and signs of hepatobiliary disease (pruritus, jaundice).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         History of liver disease with prior pregnancy: Some pregnancy-related diseases (eg, intrahepatic cholestasis of pregnancy) commonly recur in subsequent pregnancies (see
         <a class="medical medical_review" href="/z/d/html/3560.html" rel="external">
          "Intrahepatic cholestasis of pregnancy"
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3838400909">
         <span class="h3">
          Physical examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         Findings on physical examination that suggest liver disease during pregnancy (but not necessarily acute liver failure) include ascites and jaundice. A palpable liver raises concern for hepatomegaly but may be difficult to detect when the uterus is enlarged near term. (See
         <a class="medical medical_review" href="/z/d/html/89223.html" rel="external">
          "Overview of the evaluation of hepatomegaly in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2439626779">
         <span class="h3">
          Laboratory studies
         </span>
         <span class="headingEndMark">
          —
         </span>
         For pregnant patients with elevated liver biochemistries, laboratory tests that are measured during the initial evaluation include (see
         <a class="local">
          'General principles'
         </a>
         above):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Complete blood count with platelets
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Serum creatinine, electrolytes, glucose
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Prothrombin time/international normalized ratio (INR)
        </p>
        <p>
        </p>
        <p>
         Additional laboratory testing is determined based on symptoms and pattern of liver injury. (See
         <a class="local">
          'Subsequent testing'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H981191799">
         <span class="h3">
          Imaging
         </span>
         <span class="headingEndMark">
          —
         </span>
         For pregnant patients with elevated liver biochemical and/or function tests, transabdominal ultrasound of the liver is performed initially because ultrasound is widely available and has not been associated with adverse fetal effects [
         <a href="#rid1">
          1,2,9
         </a>
         ]. For patients with suspected vascular disorders (eg, right upper quadrant pain, ascites), we also obtain Doppler ultrasound study to exclude thrombosis of the hepatic or portal vein.
        </p>
        <p>
         For patients in whom biliary obstruction or cholangiopathy is suspected but ultrasound is nondiagnostic, or for some patients with abnormal ultrasonography (eg, liver mass), additional imaging with noncontrast magnetic resonance imaging (eg, magnetic resonance cholangiopancreatography) is preferred rather than computed tomography (CT) to minimize radiation exposure to the fetus. We do not use gadolinium-containing contrast agents because gadolinium crosses the placenta and may have harmful effects. If CT is necessary, the cumulative ionizing radiation exposure should be minimized, preferably less than 0.05 Gy (50 mGy, 5 rads). (See
         <a class="medical medical_review" href="/z/d/html/4791.html" rel="external">
          "Diagnostic imaging in pregnant and lactating patients", section on 'Use of gadolinium'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4791.html" rel="external">
          "Diagnostic imaging in pregnant and lactating patients", section on 'Techniques for minimizing fetal exposure'
         </a>
         .)
        </p>
        <p>
         The evaluation of an incidental solid liver lesion is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/3575.html" rel="external">
          "Approach to the adult patient with an incidental solid liver lesion"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H424159817">
         <span class="h2">
          Differential diagnosis based on initial evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         For some pregnant patients, the cause for elevated liver biochemistries can be suspected based on patient history, gestational age, initial laboratory studies, and liver ultrasound  (
         <a class="graphic graphic_algorithm graphicRef131501" href="/z/d/graphic/131501.html" rel="external">
          algorithm 1
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Liver ultrasound with or without Doppler study: Liver ultrasound may show biliary obstruction (see
         <a class="medical medical_review" href="/z/d/html/15095.html" rel="external">
          "Gallstone diseases in pregnancy"
         </a>
         ) or vascular thrombosis or ascites. (See
         <a class="medical medical_review" href="/z/d/html/3562.html" rel="external">
          "Budd-Chiari syndrome: Epidemiology, clinical manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Details of the patient's history (symptoms, medication use, comorbidities) may suggest a possible etiology:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Severe nausea and vomiting during early pregnancy suggest hyperemesis. (See
         <a class="medical medical_review" href="/z/d/html/6792.html" rel="external">
          "Nausea and vomiting of pregnancy: Clinical findings and evaluation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         New onset hypertension and/or thrombocytopenia suggest preeclampsia with severe features or HELLP syndrome  (
         <a class="graphic graphic_table graphicRef79977" href="/z/d/graphic/79977.html" rel="external">
          table 3
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/6814.html" rel="external">
          "Preeclampsia: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6778.html" rel="external">
          "HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Abdominal pain, headache, nausea, and vomiting in the third trimester is concerning for acute fatty liver of pregnancy or HELLP syndrome. (See
         <a class="medical medical_review" href="/z/d/html/3619.html" rel="external">
          "Acute fatty liver of pregnancy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6778.html" rel="external">
          "HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pruritus (with or without increased total bilirubin) suggests intrahepatic cholestasis of pregnancy. (See
         <a class="medical medical_review" href="/z/d/html/3560.html" rel="external">
          "Intrahepatic cholestasis of pregnancy"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         History of potentially hepatotoxic medication and/or supplement use suggests drug-induced liver injury. (See
         <a class="medical medical_review" href="/z/d/html/3571.html" rel="external">
          "Drug-induced liver injury"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         History of insulin resistance, polycystic ovarian syndrome, or dyslipidemia suggests increased risk for nonalcohol-associated fatty liver disease. (See
         <a class="medical medical_review" href="/z/d/html/3625.html" rel="external">
          "Epidemiology, clinical features, and diagnosis of nonalcoholic fatty liver disease in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         History of recent alcohol use raises concern for alcohol-related liver disease. (See
         <a class="medical medical_review" href="/z/d/html/86934.html" rel="external">
          "Alcoholic hepatitis: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2254546387">
         <span class="h2">
          Subsequent testing
         </span>
        </p>
        <p class="headingAnchor" id="H824640134">
         <span class="h3">
          Determining liver injury pattern
         </span>
         <span class="headingEndMark">
          —
         </span>
         For pregnant patients without a suspected etiology of abnormal liver biochemistries based on initial evaluation, subsequent testing is guided by the predominant pattern of liver injury  (
         <a class="graphic graphic_algorithm graphicRef131501" href="/z/d/graphic/131501.html" rel="external">
          algorithm 1
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hepatocellular pattern
         </strong>
         : Hepatocellular injury consists of a disproportionate elevation in serum aminotransferases compared with alkaline phosphatase. Other characteristics of liver enzymes (ie, magnitude of aminotransferase elevations) are interpreted similarly to patterns in nonpregnant patients. (See
         <a class="medical medical_review" href="/z/d/html/3576.html" rel="external">
          "Approach to the patient with abnormal liver biochemical and function tests", section on 'Laboratory tests'
         </a>
         and
         <a class="local">
          'Evaluation of acute liver failure'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Most liver disorders that are unique to pregnancy present with a hepatocellular pattern  (
         <a class="graphic graphic_table graphicRef57913" href="/z/d/graphic/57913.html" rel="external">
          table 2
         </a>
         ). Common causes of non-pregnancy related hepatocellular injury include drug-induced liver injury, viral hepatitis, nonalcohol-associated fatty liver disease, alcohol-associated liver disease, and autoimmune hepatitis  (
         <a class="graphic graphic_table graphicRef97018" href="/z/d/graphic/97018.html" rel="external">
          table 4
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cholestatic pattern
         </strong>
         : A cholestatic pattern of injury consists of a disproportionate elevation in the alkaline phosphatase compared with the serum aminotransferases. However, alkaline phosphatase will be normally elevated during pregnancy due to placental production (ie, typically &lt;2 times the upper limit of normal). In nonpregnant patients, calculating the R value can help determine the pattern of liver injury, whereas in pregnant patients, the R value will not be accurate and cannot be used to determine the pattern of liver injury. Calculation and interpretation of the R value is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/3576.html" rel="external">
          "Approach to the patient with abnormal liver biochemical and function tests", section on 'Patterns of liver test abnormalities'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Nonpregnancy-related causes of cholestatic injury include choledocholithiasis, drug-induced liver injury, primary biliary cholangitis and primary sclerosing cholangitis  (
         <a class="graphic graphic_table graphicRef99099" href="/z/d/graphic/99099.html" rel="external">
          table 5
         </a>
         ).
        </p>
        <p>
        </p>
        <p>
         Of note, serum bilirubin can be elevated in both hepatocellular and cholestatic conditions. Thus, bilirubin is not usually helpful in differentiating between the two patterns. However, jaundice is uncommon in pregnancy-related liver diseases.
        </p>
        <p class="headingAnchor" id="H3057489519">
         <span class="h3">
          Patients with hepatocellular injury
         </span>
         <span class="headingEndMark">
          —
         </span>
         Further testing for causes of hepatocellular injury includes  (
         <a class="graphic graphic_table graphicRef97018" href="/z/d/graphic/97018.html" rel="external">
          table 4
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Acute viral hepatitis:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Immunoglobulin M (IgM) anti-hepatitis A virus
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hepatitis B surface antigen (HBsAg), IgM antibody to hepatitis B core antigen, antibody to HBsAg
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Anti-hepatitis C virus antibody with reflex to hepatitis C viral RNA
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         IgM anti-hepatitis E virus (in regions where HEV infection is endemic) (see
         <a class="medical medical_review" href="/z/d/html/3677.html" rel="external">
          "Hepatitis E virus infection"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Herpes simplex virus DNA by polymerase chain reaction
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cytomegalovirus DNA assay (see
         <a class="medical medical_review" href="/z/d/html/8291.html" rel="external">
          "Overview of diagnostic tests for cytomegalovirus infection"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Epstein-Barr virus serologies (see
         <a class="medical medical_review" href="/z/d/html/8318.html" rel="external">
          "Infectious mononucleosis", section on 'Diagnosis'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Autoimmune hepatitis: Antinuclear antibodies, anti-smooth muscle antibodies, immunoglobulin G
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Intrahepatic cholestasis of pregnancy (ICP): Total bile acid concentration. Patients with ICP typically present with itching during the late second or third trimester (see
         <a class="medical medical_review" href="/z/d/html/3560.html" rel="external">
          "Intrahepatic cholestasis of pregnancy", section on 'Clinical findings'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Wilson disease: Ceruloplasmin (see
         <a class="medical medical_review" href="/z/d/html/83837.html" rel="external">
          "Wilson disease: Clinical manifestations, diagnosis, and natural history"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H146326832">
         <span class="h3">
          Patients with cholestasis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Further evaluation for causes of a cholestatic pattern of liver injury in a patient with normal liver ultrasound includes  (
         <a class="graphic graphic_table graphicRef99099" href="/z/d/graphic/99099.html" rel="external">
          table 5
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Primary biliary cholangitis: Antimitochondrial antibody
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Primary sclerosing cholangitis: Noncontrast magnetic resonance cholangiopancreatography
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Drug induced liver injury (DILI) with cholestatic features: DILI is suspected based on history of use of potentially hepatoxic drugs or supplements
        </p>
        <p>
        </p>
        <p>
         During normal pregnancy, alkaline phosphatase is elevated from placental production (typically up to twice the nonpregnant level, but sometimes markedly higher [
         <a href="#rid10">
          10,11
         </a>
         ]); thus, a mildly elevated alkaline phosphatase does not suggest cholestatic liver injury. (See
         <a class="local">
          'Liver adaptation to normal pregnancy'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H1017967305">
         <span class="h3">
          Other tests
         </span>
         <span class="headingEndMark">
          —
         </span>
         A liver biopsy is rarely necessary for the diagnosis of liver diseases that are unique to pregnancy, such as hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome, and acute fatty liver of pregnancy. Because it is invasive, a liver biopsy should be performed only when a diagnosis cannot be established based clinical presentation, laboratory studies, and imaging and when the results are needed to inform therapy or the timing of delivery. The diagnosis of HELLP syndrome and acute fatty liver of pregnancy are discussed in more detail separately. (See
         <a class="medical medical_review" href="/z/d/html/6778.html" rel="external">
          "HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets)"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3619.html" rel="external">
          "Acute fatty liver of pregnancy"
         </a>
         .)
        </p>
        <p>
         Percutaneous liver biopsy with ultrasound guidance is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/3587.html" rel="external">
          "Approach to liver biopsy"
         </a>
         .)
        </p>
        <p>
         For patients with coagulopathy, transjugular liver biopsy is an alternative approach. (See
         <a class="medical medical_review" href="/z/d/html/3586.html" rel="external">
          "Transjugular liver biopsy"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2254614187">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/112064.html" rel="external">
          "Society guideline links: Abnormal liver biochemical tests"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Normal changes associated with pregnancy impact findings on physical examination and laboratory studies and include (see
         <a class="local">
          'Liver adaptation to normal pregnancy'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Spider angiomas and palmar erythema
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Upward displacement of the liver as the gravid uterus enlarges
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Lower serum albumin level (due to hemodilution) and elevated serum alkaline phosphatase (typically &lt;2 times the upper limit of normal and due to placental synthesis)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Baseline liver biochemical and function tests are obtained in pregnant patients with any of the following (see
         <a class="local">
          'Indications for baseline liver tests'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         History of liver disease with prior pregnancy (eg, intrahepatic cholestasis of pregnancy, preeclampsia; hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome; acute fatty liver)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         History of chronic hypertension or gestational hypertension
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Risk factors for liver disease (eg, metabolic syndrome, alcohol use disorder)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Viral hepatitis identified on prenatal screening
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pregnant patients with acute severe liver injury (ie, aminotransferases typically more than 10 times the upper limit of normal, encephalopathy, and coagulopathy) have acute liver failure. Such patients require urgent consultation with maternal-fetal medicine and hepatology specialists and referral to a liver transplantation center. (See
         <a class="local">
          'Evaluation of acute liver failure'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For pregnant patients with elevated liver biochemistries but without acute liver failure, initial evaluation includes (see
         <a class="local">
          'Initial evaluation'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         History: Assess patient's risk factors for liver disease, symptoms, and gestational age
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Physical examination: Assess for findings that suggest liver disease (eg, ascites, jaundice)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Laboratory studies: Complete blood count with platelets, serum creatinine, electrolytes, glucose, prothrombin time/international normalized ratio (INR)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Imaging – Liver ultrasound (with Doppler study if vascular thrombosis is suspected [eg, patients with ascites or abdominal pain])
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For pregnant patients without a suspected etiology of abnormal liver biochemistries based on history, physical examination and initial testing, subsequent testing is guided by the predominant pattern of liver injury (hepatocellular or cholestatic)  (
         <a class="graphic graphic_algorithm graphicRef131501" href="/z/d/graphic/131501.html" rel="external">
          algorithm 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Issues related to pregnancy in patients with pre-existing liver disease are discussed separately (see
         <a class="medical medical_review" href="/z/d/html/3561.html" rel="external">
          "Pregnancy in women with pre-existing chronic liver disease"
         </a>
         ).
        </p>
        <p>
        </p>
        <p>
         <strong>
          ACKNOWLEDGMENT
         </strong>
         — The UpToDate editorial staff thank Dr. Yannick Bacq and Dr. Tram Tran for their past contributions as authors to prior versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Tran TT, Ahn J, Reau NS. ACG Clinical Guideline: Liver Disease and Pregnancy. Am J Gastroenterol 2016; 111:176.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sarkar M, Brady CW, Fleckenstein J, et al. Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021; 73:318.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Terrault NA, Williamson C. Pregnancy-Associated Liver Diseases. Gastroenterology 2022; 163:97.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Henry F, Quatresooz P, Valverde-Lopez JC, Piérard GE. Blood vessel changes during pregnancy: a review. Am J Clin Dermatol 2006; 7:65.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Turner CG, Stanhewicz AE, Wong BJ. Female Sex Hormone Effects on the Vasculature: Considering the Validity of Restricting Study Inclusion to Low-Hormone Phases. Front Physiol 2020; 11:596507.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gonzalez-Brown V, Frey HA. The Hepatobiliary System: An Overview of Normal Function and Diagnostic Testing in Pregnancy. Clin Obstet Gynecol 2020; 63:122.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ellington SR, Flowers L, Legardy-Williams JK, et al. Recent trends in hepatic diseases during pregnancy in the United States, 2002-2010. Am J Obstet Gynecol 2015; 212:524.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ch'ng CL, Morgan M, Hainsworth I, Kingham JG. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 2002; 51:876.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Torloni MR, Vedmedovska N, Merialdi M, et al. Safety of ultrasonography in pregnancy: WHO systematic review of the literature and meta-analysis. Ultrasound Obstet Gynecol 2009; 33:599.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Celik H, Tosun M, Cetinkaya MB, et al. Markedly elevated serum alkaline phosphatase level in an uncomplicated pregnancy. J Matern Fetal Neonatal Med 2009; 22:705.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vongthavaravat V, Nurnberger MM, Balodimos N, et al. Isolated elevation of serum alkaline phosphatase level in an uncomplicated pregnancy: a case report. Am J Obstet Gynecol 2000; 183:505.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 3563 Version 30.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26832651" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : ACG Clinical Guideline: Liver Disease and Pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32946672" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35276220" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Pregnancy-Associated Liver Diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16489843" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Blood vessel changes during pregnancy: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33192613" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Female Sex Hormone Effects on the Vasculature: Considering the Validity of Restricting Study Inclusion to Low-Hormone Phases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31770121" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : The Hepatobiliary System: An Overview of Normal Function and Diagnostic Testing in Pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25448511" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Recent trends in hepatic diseases during pregnancy in the United States, 2002-2010.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12427793" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Prospective study of liver dysfunction in pregnancy in Southwest Wales.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19291813" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Safety of ultrasonography in pregnancy: WHO systematic review of the literature and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19544151" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Markedly elevated serum alkaline phosphatase level in an uncomplicated pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10942498" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Isolated elevation of serum alkaline phosphatase level in an uncomplicated pregnancy: a case report.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
